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Introduction
So far more than 50 loci were shown to have robust association with systemic lupus erythematosus (SLE) . However, its genetic basis is far from understood (24) . Several limitations may have contributed to the phenomenon of "missing heritability". Firstly, genetic variants may have different allele frequencies or linkage disequilibrium (LD) structures across major ethnicities, or even in different populations of the same ethnicity, so the pattern of disease association might be different between different populations (25) , making it difficult to replicate previous findings and to predict risk. It is also possible that different variants in a gene having no LD to each other are associated with the underlying disease in different populations similar to what was shown for IRF8 (15) . Thus, replication efforts from different populations that focused on single reported SNPs may miss the association signal.
The second limitation may come from the insufficient exploration of independent effects within an individual locus. These independent contributors are often overlooked in the subsequent replication steps, and the validation of their effects may require much larger sample sizes than available in most studies. Additionally, the coverage of many genomic regions in the early stage SNP chips was also limited;
hence reducing the chances of capturing independent contributors. However, there was strong support on the contribution from multiple independent effects from a 8 single locus to disease susceptibility. A recent study demonstrated multiple independent contributors in a number of risk loci for several complex diseases, and those independent contributors within a locus could explain more disease heritability than the single reported SNP (26) . The same scenario might also be true for SLE. Two out of five loci showed evidence of independent effects in our recent study on SLE in Asian populations (15) , and detection of independent contributors near an established locus was also reported recently (27) .
Gene-or region-based association analysis is an approach that may improve the power of GWAS. Generally, this approach tests whether a set of SNPs in a given gene or region shows evidence of association with a trait of interest. Gene-based analysis has several attractive advantages (28) . Firstly, by focusing on the association signal from the entire gene rather than the individual SNPs, it could detect associated genes with multiple independent effects of small effect size, which could have been missed by a single variant-based analysis. Besides, gene-based analysis can also alleviate the issue resulted from insufficient chip coverage of earlier GWASs (29) . The effect from the untyped causal SNP might be captured more efficiently via detecting the joint effect of multiple markers that are in LD with it. In addition, this approach also reduces the multiple-testing burden of GWAS, since it only requires correction for ~20,000 genes rather than the hundreds of thousands of SNPs tested in a typical GWAS. Furthermore, the characteristics of a gene, such as its position, sequence, and function, are highly consistent across human populations. Therefore, gene-based 9 analysis is more likely to yield consistent results across major ethnicities, and it also provides an opportunity for understanding genetic findings at the functional level (25, 30) .
Several gene-based association methods have been proposed, such as regression-based tests (25) and integration of the SNP-based test statistics or P values from a gene (31, 32) . In the regression-based tests, all the SNPs in the genes are entered as predictor variables simultaneously, except for the redundant SNPs. This approach might suffer from low statistical power due to the high dimensionality. In addition, the requirements of raw genotype data and heavy computational demand also limited their application on a genome-wide scale. Recently, Li et al. (28) proposed GATES (Gene-Based Association Test using Extended Simes procedure) as an efficient approach for gene-based test via combination of SNP statistics. Using an extended Simes procedure, GATES integrates the P values of all the contributing SNPs within a gene and its up-and down-stream regions, obtaining an overall association P value for the gene. It could achieve comparable statistical power to other alternative gene-based analysis methods, and showed better performance when a gene has only one independent signal (28) . This method has been successfully applied in the identification of variants conferring risk of schizophrenia in Han Chinese (33) .
In this study, based on the meta-analysis of two SLE GWASs conducted on two Chinese populations (15) , we performed an in-depth gene-based analysis by GATES and followed the findings by replication in a total of 4,626 cases and 7,466 controls in 10 several Asian cohorts. Our results confirmed most SLE susceptibility genes identified previously at the single SNP level, and showed widespread presence of independent effects among these genes. In addition, we identified ANXA6 as a novel SLE susceptibility gene with multiple independently contributing variants, and the results provide new insight on the genetic architecture of this prototypic autoimmune disease.
Materials and Methods
Subjects
Samples used in this study were overlapped with our previous study (15) 
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Genotyping
The two GWASs from Hong Kong and Anhui were conducted as previously reported (15) , both by Illumina 610-Quad Human Beadchip array. Further replication on selected SNPs was performed by TaqMan SNP genotyping method using assay-on-demand probes and primers (Applied Biosystems, Foster City, CA, USA), Catalogue nos. C__8723142_10 for rs1561535, C__29329619_10 for rs6707773, C__25934588_10 for rs3815700, C__11836916_10 for rs4958893, C__31986133_10 for rs11960458, C__29349750_10 for rs6896621, C__7513840_20 for rs868531, C__15758511_10 for rs2303028, C__3169127_20 for rs10036748. The accuracy of genotyping was confirmed by direct sequencing of PCR products for 96 randomly chosen samples, which showed 100% concordance. Genotyping concordance between Illumina Human 610-Quad Beadchip and Taqman SNP genotyping method was also checked on randomly selected samples and the two methods showed complete concordance.
Association analysis
The association analysis and meta-analysis were performed as previously described (15) . The quality control process included removing SNPs with low call rate (<90%), low minor allele frequencies (<1%), and violation of Hardy-Weinberg equilibrium in controls (P ≤ 10−4), and removing samples with low call rate (<90%) and hidden relationship detected using PLINK (32) . Then we applied two principle components (PCs) corrections to the whole genome association statistics on the two GWAS datasets. Two major PCs, PC1 and PC2 were added as covariates to adjust for Page 13 of 58
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Asians from the 1000 Genome project (June 2011 data release) as the reference.
Imputed SNPs with an information score >0.9 were included for further analyses. The same quality control criteria were applied to process imputed SNPs. Joint analysis of association, taking into consideration the differences between cohorts, was performed using Cochran-Mantel-Haenszel, and homogeneity of effect size between diverse cohorts and different stages of the study was examined by Breslow-Day test (P_ het in Table 2 ), both installed in PLINK. Test of independent effects towards disease association for SNPs in a single locus was done using logistic regression by PLINK, adjusted by the effect of the other SNPs in the same locus, also treating cohort as a covariate.
Gene-based and region-based analysis
GATES (28) , which implemented in KGG (35) software package was used to perform gene-based analysis. SNPs were mapped onto genes according to gene coordinate information from NCBI GRCh37, and SNPs within 10 kilobase pairs (kb) both upstream and downstream of each gene were also included. A SNP that was located in the overlapping region of two genes was assigned into both genes. The r-square (r 2 ) Page 14 of 58
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The construction of Gene-Based-Association P values was done as described previously (28) . Briefly, let P (1) , …, P (m) be the ascending p values of m SNPs within a gene, the overall P value for the gene is calculated as follows:
Where m e is the effective number of independent P values among the m SNPs and m e(j)
is the effective number of independent P values among the top j SNPs. After correction for multiple testing, the significance level for Benjamini & Hochberg (1995) FDR test (36) to control the error rate at 0.05 on the whole genome was 2.0E-4 for the 23,411 genes tested. Briefly, the P values of each gene are ranked in ascending order and denoted by P (1) …P (m) . Then, the Benjamini & Hochberg procedure controls the false discovery rate (α=0.05 here). The procedure works as follows: 1) For a given α, find the largest κ such that ܲ(ߢ) ≤ analysis (PCA), the two Chinese populations did not seem to have significant differences in terms of population structure. There was no substantial difference for the SNP-based P values before and after admixture adjustment, as majority (99.83%)
of them differed within one order of magnitude ( Figure S1 ). SNP-based P values after admixture adjustment were subjected to gene-based analysis using GATES. A total of 324,519 (60.44%) SNPs were mapped to one or more of the 23,411 genes. The inflation factor of gene-based association was 1.047. We examined the Quantile-Quantile plot (Q-Q plot) comparing expected and observed gene-based P values by removing genes in known susceptibility loci (4-6, 9, 10, 12-16, 18-20, 23, 27) . After removal of these genes, we still observed an excess of association signal ( Figure S2 ), suggesting additional associated genes for the disease. After correction for multiple testing, 83 genes reached gene-based genome-wide significance (P<2.0E-04), of which 41 genes were located in non-MHC regions. Twenty-five of the 41 genes within 18 loci were located in regions already established for SLE association in earlier studies based on single variant analysis ( Table 1) . Some of these genes are close to each other and located in the same LD block, thus were assigned into the same locus, such as LRRC18 and WDFY4, HIC2 and UBE2L3, and BLK and FAM167A.
It was shown that Ten of the eighteen known SLE susceptibility loci showed potential evidence of containing multiple independent contributors (P_ adjusted <0.05
and P_ unadjusted <0.001, Table 1 , upper panel). The independent effects within nine of Therefore, the results of gene-based analysis were proven consistent with what have been reported in the literature. For other potentially independent variants in the reported loci that did not reach genome-wide significance, their roles in disease association need confirmation through replication in additional samples.
The results also suggested 16 novel non-MHC genes within 13 loci might be associated with SLE. Three of them showed potential evidence of independent effects (Table S1 ). Thus, we performed replication on the best SNPs of these three loci, using 2,970 additional SLE cases and 4,072 controls collected from Hong Kong, Anhui and Thailand. A joint analysis of results from all three cohorts showed that an intronic variant in ANXA6 (annexin Ⅵ) demonstrated significant SLE association (rs4958893, P_ combined =3.12E-07, Table S2 ), and this locus was followed up further. A flowchart describing the steps taken in the current study was shown in Figure 1 .
Region-based association analysis
In order to detect association signals located in the intergenic regions, we designed a modification that would allow consideration of all the intergenic regions in a gene-based analysis (See Materials and Methods for details). After correction for multiple testing, we found additional 38 intergenic regions reaching genome-wide Table S3 ). Interestingly, with such modification, we further identified association signals from miR146a, PRDM1 and IKZF1 regions that were missed from analysis when the intergenic regions were not systematically considered.
ANXA6 locus in association with SLE
We examined the meta-analysis results in ANXA6 region, and there were eleven SNPs that showed P_ meta <0.001 (Table S4 and Figure 2a ), and LD patterns among them revealed that they could be grouped into five clusters ( Figure S3 ). Imputation followed by meta-analysis was performed to obtain information on additional SNPs in this region. However, none of those imputed SNPs showed P values of higher significance than the interrogated SNPs. Additionally, there is no adequate evidence supporting their independent functional potentials on disease pathogenesis that would warrant additional replication. For example, none of them resulted in amino acid substitutions (Table S5 , by SCAN annotation). RegulomeDB annotations were also investigated to identify SNPs in or near regulatory elements, and several such imputed SNPs were shown to have potential regulatory functions. However, these SNPs were all shown to have high LD with the genotyped SNPs (Table S5 , RegulomeDB Page 20 of 58
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This article is protected by copyright. All rights reserved. 20 annotation). Therefore, four additional SNPs, namely rs11960458, rs6896621, rs868531, and rs2303028, all interrogated in the GWAS stage, were selected for further replication to identify independent effects within ANXA6. In order to exclude the possibility that the association of ANXA6 with SLE was dependent on the effect of the neighboring TNIP1, a gene that was previously reported for SLE association (13), SNP rs10036748 was also included for replication in additional samples. Table 2 showed that both rs11960458 and rs6896621 revealed suggestive significance for SLE association by joint analysis of data from all three cohorts (P_ combined =5.66E-07 and 6.72E-06, respectively). The association of SNP rs10036748 in TNIP1 was also replicated in the current study (P_ combined =1.94E-10).
Results in
For SNPs rs4958893, rs11960458, rs686921 and rs10036748, the same trends were observed in all the replication cohorts ( Figure S4 ). Importantly, independence tests showed that SNPs rs4958893, rs11960458, and rs6896621 remained significant when the effect from rs10036748 in TNIP1 was adjusted for (shown as conditional P a ).
Furthermore, independent effects also existed among these four SNPs, since each SNP remained significant when the effects from the other three SNPs were all adjusted for (shown as conditional P b ). Consistent with the results of independence tests, these SNPs had low to moderate LD between each other (r 2 < 0.4, Figure 2b ). In addition, the extended association down to GPX3 observed from the data might be due to the TNIP1 association, as indicated by the LD pattern between rs10036748 and the SNPs in this region ( Figure S5 ). SNPs in GPX3 were in moderate to high LD with 
Arthritis & Rheumatology
This article is protected by copyright. All rights reserved. 21 rs10036748, and their P values were no longer significant when the effect from rs10036748 was adjusted for by logistic regression (Shown in Table S6 ).
ANXA6 expression profile and eQTL analysis
In order to detect potential functions of the SNPs in transcription regulation, we queried the publicly available expression quantitative trait locus (eQTL) database GHS Express, which assessed the transcriptome of circulating monocytes in 1,490 unrelated individuals (41) . We found that rs4958893 was in absolute LD (r 2 =1) with rs868641, a cis eQTL for ANXA6 (P=3.41E-11). Additionally, the regulatory effect of rs868641 on ANXA6 expression in monocytes has also been confirmed by a recent study on cell type-specific eQTL analysis (42) . SNP rs11960458 was also in high LD (r 2 =0.94) with another cis eQTL for ANXA6 (rs4958891, P=1.41E-10). Detailed results of the eQTL analyses were shown in Table S7 -S8.
Interestingly, SNP rs11960458 is located in the 3'UTR of ANXA6 and we speculated that it may affect the expression level of ANXA6 or is in high LD with a variant that does. Therefore, we examined allelic differential expression of ANXA6 from the two alleles of rs11960458 in peripheral blood mononuclear cells (PBMCs) from healthy individuals of Hong Kong Han Chinese population who are heterozygous on the SNP (n=43). The risk allele (T) was found to be significantly correlated with a higher level 
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Discussion
In this study, using gene-based test of meta-analysis results from two Asian GWASs, we confirmed multiple SLE susceptibility genes that were established before, and showed the widespread presence of independent effects among known susceptibility genes for SLE. Importantly, we identified ANXA6 as a novel susceptibility gene for SLE, which contained several independent contributors.
ANXA6 did not contain a single SNP that could potentially reach genome-wide significance based on the current sample size, their effect size and allele frequency.
Thus, the association of this gene would not have been recognized without application of an alternative approach such as the gene-based association analysis. We also identified rs11960458 as a regulatory SNP (rSNP) with its risk allele correlating with higher expression of ANXA6, providing a functional interpretation for the genetic association.
ANXA6 showed high expression level in immune-related cells, and increased expression of ANXA6 was also observed in SLE cases ( Figure S6-S7 ). In addition, ANXA6 protein was shown to interact with human complement receptor 2 
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Epstein-Barr virus (EBV) binding on B and T cells, and plays a central role in the
immune responses to foreign antigens and the development of autoimmunity to nuclear antigens in SLE (44) . EBV has been considered as an important environmental trigger for SLE (45, 46) . Additionally, genetic variations in CR2 were found to be associated with SLE (47, 48) . Thus, the potential functional link between ANXA6 and CR2 supported the genetic findings on ANXA6 as a novel SLE susceptibility gene.
Furthermore, two variants in ANXA6 (SNP rs4958893, and rs11960458) were in high LD with eQTLs that affecting ANXA6 expression. SNP rs11960458 , which is located in the 3'UTR of ANXA6, showed evidence of allelic differential expression with the risk allele correlating with a higher expression of ANXA6. These data indicate that multiple mechanisms may be involved in the disease association of this locus.
Interestingly, rs11960458 was also mapped onto a miRNA binding site of ANXA6 in Sanger's miRBase (http://www.mirbase.org/). Destruction of the miRNA binding site (such as for miR-1234-3p and miR-4479) by this SNP might confer increased expression/stability although the detailed mechanisms still require further investigation. A summary of the current findings and the potential link between ANXA6 with autoimmunity were shown in Figure 4 .
The current study also suffers from several limitations and the exploration of SLE susceptibility genes is by no means complete. Genes like ARID5B, ITGAM, and
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DRAM1, whose associations have been identified in our previous studies, did not show strong evidence of association when analyzed at the gene level. One of the underlying reasons is the definition of gene boundary. As reported by the ENCODE (The Encyclopedia of DNA Elements) project, the majority of the regulatory elements are located close to the gene although distant ones do exist (49) , herein, the gene boundary was defined as 10kb up-and down-stream of each gene in the current study.
The range of gene boundary, which determines the number of SNPs to be analyzed for the gene, may affect the results of gene-based associations. It is also important to recognize that there is a tradeoff for the gain in power for this method, since it may mask or dilute individual SNP effects when the SNPs in a gene are considered altogether, especially for large genes, such as ARID5B, DRAM1, and ITGAM as mentioned above. The lack of convincing signal in ITGAM might also be attributable to the low allele frequency of risk SNPs in this gene in Asian populations (MAF<5%, (11) ).
In addition, a gene-based analysis can only cover SNPs within or near a gene, and some intergenic SNPs may also be associated with complex diseases and could be missed by this approach. In order to solve this issue, we designed an in-house algorithm to consider all the intergenic regions larger than 10kb in a gene-based association analysis. We found that most of the intergenic regions that showed significant association signals were those in high LD with the known association loci or candidate loci identified by the analysis only considered the real genes. 25 Interestingly, with such modification, we successfully identified the association signals from miR146a, PRDM1 and IKZF1, which were not prominent by the gene-based method using a strict definition of genes. This region-based approach might find its usefulness in applying in the studies of other complex diseases. We have made this modification available from our laboratory website (paed.hku.hk/genome).
Recently, a re-sequencing-based study was conducted on 24,892 subjects with six autoimmune disease phenotypes and 17,019 controls (50) . It concluded that many common variants with weak effect might have significant contribution to the missing heritability for complex diseases. These results support the merit of using gene-based approach for exploring independent effects in susceptibility loci for complex diseases.
Additionally, with the support of many integrated bioinformatics databases, the application of gene-based approach could be further extended to explore novel biological pathways and protein-protein interaction networks that may play an important role in complex diseases. 26 
Figure legends
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b For the four SNPs, rs10036748, rs4958893, rs11960458 and rs6896621, we show the P value of the SNP when adjusted by the effect of the other three SNPs. PBMC cDNA and DNA prepared from 43 healthy individuals heterozygous on rs11960458 were used for allelic differential expression analysis of ANXA6 by pyrosequencing. Shown are the ratio of T/C allelic detection for both DNA and cDNA. The median T/C ratio for DNA is 1.08 (95% CI: 1.07-1.11) and the median T/C ratio for cDNA expression is 1.18 (95% CI: 1.15-1.29), P=0.0017 by paired student's t test on the difference of the ratios. 95x74mm (300 x 300 DPI) 
